Aseptuva
Non Equity Assistance in 2024
Aseptuva is an early-stage MedTech company based in Technopark Winterthur. It aims to combat Healthcare-Associated Infections (HAI) by developing medical devices for in-situ disinfection of various catheters, preventing infections at their source and potentially saving thousands of lives annually.
HeroSupport
Non Equity Assistance in 2024
HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.
Selmod
Non Equity Assistance in 2021
Selmod, based in Basel's life science hub, develops innovative antibiotics targeting multi-drug resistant infections. Its first-in-class drug candidates focus on high-revenue hospital patients where first-line treatments have failed due to resistance. With a disruptive approach featuring new dual modes of action, all candidates have shown success in animal infection studies. The company aims to capture a significant share of the estimated $9 billion total available market for its three lead assets.
Eaternity
Non Equity Assistance in 2021
Eaternity develops a software management platform for the restaurant industry that provides real-time calculations for allergen and nutrition declarations and estimates the carbon footprint of meals and restaurant operations. The platform also tracks supply-chain data and delivers insights to support smart decision-making toward a more sustainable food system. Through the Eaternity Score, the environmental impact of food products is made transparent to consumers and decision-makers. The company was founded in 2014 and is based in Zurich, Switzerland.
Oxyle
Non Equity Assistance in 2021
Oxyle specializes in wastewater treatment, focusing on the removal of hazardous micropollutants such as pesticides, chemicals, pharmaceuticals, and endocrine disruptors. Serving industries like pharmaceuticals, biotech, chemicals, food & beverage, electronics, hospitals, and wastewater plants, Oxyle's innovative technology helps reduce toxic pollutants and carbon emissions while providing regulatory relief to clients.
Plastogaz
Non Equity Assistance in 2021
Plastogaz is a Swiss company based in Lausanne that specializes in the production of natural gas from waste resources, particularly synthetic waste streams like plastics. Founded in 2019, it utilizes a patented catalyst technology to convert mixed plastics into grid-compatible methane and naphtha, which can serve as fuel or be used for creating new synthetic materials. By transforming plastic waste into usable products, Plastogaz aims to mitigate greenhouse gas emissions and contribute to a more sustainable environment. The company's innovative approach not only addresses the challenges of plastic disposal but also helps reduce the carbon footprint associated with traditional waste management practices.
Authena
Non Equity Assistance in 2021
Authena specializes in unit-level condition monitoring traceability solutions. It combines proprietary IoT devices, blockchain, and AI technologies to provide real-time tracking for industries such as pharmaceuticals, luxury goods, and food & beverage. Authena's offerings, including Authena SHIELD™ and Authena L1VE (Next Generation), enhance regulatory compliance while fostering consumer trust through transparency and commitment to sustainability.
VAY
Non Equity Assistance in 2021
VAY is a Zurich-based computer vision company that specializes in human motion analysis, utilizing advanced technology to digitize human movements through a simple camera. Founded in 2019, VAY develops innovative solutions that make products smarter, more interactive, and immersive by leveraging real-life data and feedback. Their platform employs artificial intelligence to accurately perceive and predict human motion, facilitating seamless interaction between digital systems and users. The company's hardware and system agnostic approach allows for versatile applications across various sectors, including health, sports, and gaming, providing valuable insights for physiotherapy, rehabilitation, and gait or posture analysis.
NaturLoop
Non Equity Assistance in 2021
NaturLoop is a Swiss-based cleantech and material science company focused on sustainable development through the production of natural biocomposites. It engineers biocomposites from agricultural waste using bio-based adhesives and scalable manufacturing, including a turnkey micro-factory concept to enable industrial production. The company develops commercially viable products and aims to mitigate natural resource depletion while integrating rural communities into the value chain. It also manufactures coconut-based fiberboards made from agroforestry waste via an accessible, low-tech process, providing affordable, sustainable building materials by leveraging existing wood panel infrastructure and supporting circular economy practices.
Lyfegen
Non Equity Assistance in 2020
Lyfegen is a global, independent provider of drug access, pricing and rebate management solutions, headquartered in Basel, Switzerland, with offices in Boston, USA. The company offers software and services to help healthcare payers and pharmaceutical companies identify appropriate price agreements, simulate and understand the financial impact of those agreements, and automate the execution and adjudication of rebates, reducing administrative effort. By enabling more efficient rebate management, Lyfegen aims to improve patient access to therapies, affordability, and overall health outcomes.
Readily3D
Pre Seed Round in 2020
Readily3D is a Lausanne, Switzerland-based company that commercializes volumetric tomographic 3D printers and bioprinting solutions. A spin-off from École Polytechnique Fédérale de Lausanne, it was founded in 2020 after researchers developed tomographic printing methods starting in 2017. The company's printers enable centimeter-scale, tomographic 3D printing of cells and biomaterials with optical resolution below 100 micrometers, and are paired with software that imports design files, optimizes print parameters, and minimizes cell stress and light exposure. This technology supports rapid prototyping of living tissue constructs and statistically meaningful biological models for life sciences research.
aquama
Non Equity Assistance in 2020
Created in Switzerland, Aquama® offers an innovative solution for cleaning and disinfecting with electrified water and salt, within an application system (Apple / Google/ Huawei). Thanks to this technology, professionals and individuals benefit from a detergent and disinfectant solution, at a competitive price and without toxicity. A revolution that allows both to limit costs and reduce pollution. ECOLOGY, ECONOMY AND EFFICIENCY Born in the hospitality sector, Willy Lionel Pomathios began to take an interest in ecology 10 years ago. In 2013, thanks to his collaboration with Aquama® engineers, he created a detergent and disinfectant solution consisting only of water, salt and electricity. Thanks to this hydrolysis process, water is rid of all chemical and toxic substances, a real revolution in the field of cleaning.
Amphasys
Non Equity Assistance in 2020
Amphasys develops and markets chip-based single-cell analysis technology, aiming to simplify, speed up, and miniaturize complex cell analyses for various applications. Founded in 2012 as a spin-off from Axetris AG, the company's technology enables label-free analysis of cell characteristics such as size, morphology, viability, and differentiation.
Exomotion
Non Equity Assistance in 2020
Exomotion SA is a Swiss company founded in 2018, located in Plan-les-Ouates, Geneva. The company specializes in the development of innovative personal mobility devices that utilize robotics technology. Exomotion's products are designed to enhance omnidirectional movement, featuring electronic movement systems that combine electrical boards with motion sensors and a wheeled mechanism. This technology enables the devices to move in any direction and rotate instantly, significantly improving the user experience. By rethinking the concept of e-mobility, Exomotion aims to enhance mobility solutions with a focus on omnidirectionality and safety.
Synthara
Non Equity Assistance in 2020
Synthara is a Swiss semiconductor company focused on in-memory computing for embedded chips and smart sensor applications. It develops ComputeRAM, a drop-in memory-based compute technology that performs complex calculations directly in memory, reducing CPU workload and improving performance for AI workloads. The technology targets energy-constrained environments and applications including wearables, hearing aids, biomedical monitoring, AR/VR, and industrial IoT sensors, as well as drones, autonomous navigation, space, aerospace, and automotive use cases. Synthara's approach is processor-agnostic and can be integrated with existing microcontrollers to boost energy efficiency and latency without redesigning silicon. The company supports chipmakers and device manufacturers seeking lower costs, shorter time to market, and greater computational throughput. Based in Zurich, Synthara emphasizes enabling seamless adoption of in-memory computing across embedded platforms to extend battery life and unlock new opportunities for intelligent sensing.
Founded in 2016, Smeetz is a Swiss-based company offering an AI-powered commerce intelligence platform tailored for the leisure and entertainment industry. Its comprehensive suite of solutions includes ticketing, POS, CRM, data analytics, and dynamic pricing, empowering venues to optimize efficiency, increase revenue, and enhance guest experiences.
Hi-D Imaging
Non Equity Assistance in 2020
Hi-D Imaging AG is a Swiss company established in 2019, specializing in advanced imaging technologies for cardiovascular disease, particularly focusing on heart valve replacement. The company offers a SaaS-based pre-operational planning platform that assesses the hemodynamics of patient-specific anatomies. This platform enables physicians to analyze blood flow patterns and select the optimal size and shape of heart valves prior to trans-catheter aortic valve implantation. By providing detailed imaging and in-vitro fluid dynamic analysis, Hi-D Imaging empowers medical professionals to make data-driven decisions tailored to individual patient needs, thereby improving surgical outcomes and reducing the necessity for additional medical imaging. The company is headquartered in Winterthur, Switzerland.
CellSpring is a biotechnology company based in Zurich, Switzerland, that develops 3D tissue models for biological research. Its core offering, the 3D Bloom platform, enables rapid creation of biomimetic microtissues independent of cell type, supporting in vitro studies and drug development. The platform emphasizes speed, reliability, versatility, and ease of use, improving the fabrication of 3D cell cultures for diverse experimental applications.
PXL Vision is a Swiss identity verification software provider focused on automated, AI-based onboarding and fraud prevention. Its cross-platform Daego solution creates trusted digital identities for customer onboarding by verifying identity documents and performing liveness checks through computer vision and machine learning. Founded in 2017 and headquartered in Zurich, the company operates research and development centers in Novi Sad and Yerevan to advance high-performance ML-based verification. PXL Vision serves industries such as insurance, gambling, fintech, banking and healthcare with a modular, configurable system that supports fully automated identity verification, reduces dropout, improves onboarding conversion, and helps businesses comply with regulatory requirements while protecting customer data. The company emphasizes reliable verifications and safe digital interactions by leveraging proprietary machine learning to confirm document authenticity and user identity.
Enterprise Bot
Grant in 2019
Enterprise Bot provides an AI-powered conversational automation platform for enterprises to automate customer interactions and streamline internal processes. Its platform builds chatbots, virtual assistants, and voice bots that operate across multiple channels to improve customer experience and reduce costs. The company serves financial institutions and insurance enterprises, and offers products such as chatbots, email triage bots, and scheduling assistants. Founded in 2017, it is based in Zug, Switzerland, with an office in Bengaluru, India.
Artiria Medical
Grant in 2019
Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.
Planted Foods
Grant in 2019
Planted Foods AG is a Swiss company founded in 2019, specializing in the development of plant-based meat alternatives. The company produces products such as planted chicken and BBQ planted chicken, utilizing a formulation that includes pea protein, pea fiber, sunflower oil, and water to replicate the taste, texture, and mouthfeel of traditional animal meat. Planted Foods employs advanced technology to transform these natural ingredients into nutritious, high-protein meat substitutes that appeal to consumers seeking plant-based options. In addition to its product offerings, the company operates an e-commerce platform to facilitate direct sales to customers. Headquartered in Zürich, Switzerland, Planted Foods is committed to providing delicious and sustainable meat alternatives.
Clemedi
Non Equity Assistance in 2019
Clemedi AG is a Swiss-based company founded in 2018 that specializes in developing diagnostic workflows for infectious diseases. The company creates in vitro diagnostic tests by integrating next-generation sequencing and machine learning technologies. These innovative tests are designed to diagnose drug-resistant infections directly from patient samples within a single day, supporting timely and personalized antibiotic therapy. By providing healthcare professionals with critical information, Clemedi aims to enhance decision-making in the treatment of infectious diseases, ultimately contributing to the fight against antibiotic resistance. This approach is particularly significant given projections that antibiotic-resistant bacteria could lead to 10 million deaths annually by 2050.
Hempfy
Non Equity Assistance in 2019
Hempfy is a Swiss company specializing in the production of innovative, THC-free hemp-infused food and beverages. Utilizing proprietary cold infusion technology, Hempfy cultivates, harvests, and processes hemp plants in compliance with Swiss legislation. All products are 100% Swiss-made, with a focus on bespoke quality, from seed selection to final production. Hempfy aims to replace smoking and alcohol as the world's preferred social drug, offering cannabis-based products with a balanced taste and light carbonation.
Regenosca
Non Equity Assistance in 2019
Regenosca SA is a Swiss company based in Lausanne, established in 2019, that specializes in the development and commercialization of innovative medical devices for bladder reconstruction. The company focuses on creating sterile, off-the-shelf implants that serve as viable alternatives to autologous tissue substitutes for soft tissue repair. By leveraging advanced biomaterials technology, Regenosca aims to facilitate regeneration rather than scarring, thereby enhancing patient outcomes and preserving bladder function. Their products are designed to be easy to use, ultimately improving the quality of life for patients undergoing bladder surgeries.
Microcaps
Non Equity Assistance in 2019
Microcaps develops microencapsulation technology that protects and controls the release of active ingredients in pharmaceuticals, probiotics, and cosmetic formulations. Leveraging microfluidics and step emulsification, the company produces monodisperse microcapsules and microparticles at scale, enabling precise size control, dosing, and greater stability. Its platform supports liquid oil core microcapsules with natural alginate shells, improving throughput without quality loss. Based in Zurich, Switzerland, Microcaps targets applications across drug delivery, probiotic encapsulation, and fragrance or cosmetic encapsulation, offering automated encapsulation production capable of high-throughput manufacturing for complex formulations.
OxyPrem
Non Equity Assistance in 2019
OxyPrem AG is a Swiss company that specializes in the development, design, and manufacturing of advanced sensor solutions specifically for monitoring preterm infants. Established in 2018 and headquartered in Zurich, the company offers a reusable device that continuously measures hemoglobin oxygen saturation in the brains of high-risk preterm infants. By utilizing harmless near-infrared light technology, OxyPrem provides real-time monitoring, which significantly enhances the clinical care provided to this vulnerable patient group. The innovations from OxyPrem aim to prevent early death and severe long-term brain damage, thereby minimizing the risk of disabilities and other complications associated with premature birth.
Dimpora
Non Equity Assistance in 2019
Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly functional membranes for the outdoor textile industry. The company produces waterproof, fluorine-free membranes primarily made from polyurethane, utilizing a template removal approach to create porosity that enhances breathability. Dimpora's innovative technology allows for the direct application of membranes onto various surfaces, facilitating fast moisture transport while ensuring complete rain protection. Committed to sustainability, Dimpora aims to develop high-performance membranes that enable outdoor enthusiasts to enjoy nature responsibly, with a focus on creating next-generation solutions that may incorporate recyclable materials.
iWin
Non Equity Assistance in 2019
iWin, based in Manno, Switzerland, specializes in the development of an innovative photovoltaic venetian-blind shading device that is seamlessly integrated into insulating windows without affecting their design or functionality. Established in 2019, the company aims to enhance building sustainability, as the construction sector is responsible for approximately 40% of global CO2 emissions. The patented system not only generates renewable energy on-site but also effectively controls light and solar radiation, protecting buildings from overheating in summer. iWin’s product is customizable in size and color, durable, and requires minimal maintenance, boasting a payback period of less than ten years. The company has created its first working prototype and has formed partnerships with SUPSI and Pellini Group, a leader in integral venetian blinds. With a significant market opportunity, particularly in Switzerland where around 900,000 square meters of glass façades are installed annually, iWin is poised for growth in the sustainable building sector.
Logmind
Non Equity Assistance in 2019
Logmind designs a cloud-based, AI-accelerated log data analytics platform that provides visibility into unstructured log data and automated insights. The platform enables IT operations and DevOps teams to automatically detect application issues, investigate and discover root causes, visualize and monitor trends, and receive alerts and recommendations. It analyzes logs from complex IT infrastructures to transform scattered data into operational intelligence, helping organizations run applications more reliably and avoid costly incidents. Established in 2018 and based in Lausanne, Switzerland, Logmind focuses on turning unstructured log streams into actionable, real-time insights.
Terapet
Non Equity Assistance in 2019
Terapet specializes in advanced proton therapy for cancer treatment. Founded by physicists Christina Vallgren, Marcus Palm, and Professor Raymond Miralbell from Geneva University Hospitals, the company offers precise radiotherapy that minimizes harm to healthy cells. Incorporated in 2019, Terapet is based in Geneva, Switzerland.
Dronistics
Non Equity Assistance in 2019
Dronistics is a Swiss company based in Lausanne that specializes in developing a personal and user-friendly drone delivery system designed for last-centimeter delivery to hard-to-reach locations. Its innovative system utilizes autonomous drones, which are equipped with GPS technology and controlled through a web application accessible on various devices, including smartphones, tablets, and laptops. The drones are connected to the internet via a 4G modem, enabling seamless operation. To ensure safety during flights and while unloading packages, Dronistics incorporates a series of safety checks into its software. This technology allows logistics and online retail companies to effectively address delivery challenges in remote areas, providing a reliable solution for modern delivery needs.
Plair SA
Non Equity Assistance in 2019
Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.
Authena
Non Equity Assistance in 2019
Authena specializes in unit-level condition monitoring traceability solutions. It combines proprietary IoT devices, blockchain, and AI technologies to provide real-time tracking for industries such as pharmaceuticals, luxury goods, and food & beverage. Authena's offerings, including Authena SHIELD™ and Authena L1VE (Next Generation), enhance regulatory compliance while fostering consumer trust through transparency and commitment to sustainability.
EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.
Biospectal is a remote patient monitoring and biosensing software company that has developed the OptiBP smartphone app, which allows users to measure and monitor blood pressure with medical-grade accuracy using their smartphones. The app utilizes the phone's built-in camera to optically measure blood flow from the user's fingertip, providing results in approximately 20 seconds, which is significantly faster than traditional blood pressure cuffs. Biospectal's proprietary algorithms interpret the captured data to deliver accurate blood pressure readings. The OptiBP app is currently available in public beta for Android users in several countries, including the United States, United Kingdom, France, Germany, Spain, and Switzerland. This innovative approach enables users to perform blood pressure measurements anytime and anywhere without the need for additional devices or accessories.
Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.
Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.
Securaxis
Pre Seed Round in 2018
Securaxis develops, installs, and operates innovative safety and security solutions, focusing on real-time geolocalized security information. Founded in 2018 as part of the BIC of CERN Technologies in Switzerland, the company is recognized for its achievements, including participation in various startup programs and awards. Securaxis utilizes a smart acoustic sensor connected to a wireless network to analyze and classify sounds in urban environments, allowing for accurate reporting of potential security threats. This technology enables organizations to enhance safety measures by making informed decisions based on real-time data. The team consists of eight experts in machine learning, acoustics, data management, and entrepreneurship, who have successfully developed and commercialized a mobile security application for notable clients, including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations.
Akselos
Venture Round in 2018
Akselos is a technology company that develops Integra, a cloud-based engineering simulation platform and digital twin for asset-centric industries. The platform enables engineers to build high-resolution, component-based models of large systems and run parameterized simulations that cover geometric and physical properties, loads, and boundary conditions. It supports hydrodynamic analysis of floating assets and structural assessment of fixed offshore installations, as well as analysis of composites used in wind blades, pressure vessels, pipelines, and rotating machines. Designed for design, virtual prototyping, and real-time monitoring, Integra leverages fast, patented algorithms that can model large-scale assets on portable hardware. The company's vision emphasizes preventative maintenance and reduced unplanned downtime through real-time asset condition and future-state insights, often described as a digital twin with sensors and big data analytics. Akselos was founded in 2011 in Lausanne, with a Cambridge, Massachusetts office and operations in Europe, the USA, and Southeast Asia.
Aesyra
Non Equity Assistance in 2018
Aesyra is a Swiss medical device company based in Lausanne that designs and commercializes intra-oral sensors and compact oral appliances to monitor and manage sleep-related conditions such as bruxism and obstructive sleep apnea. The company develops devices that embed sensors to collect and display metrics, enabling dental professionals to reduce occlusal damages to dental prostheses and helping individuals pursue better sleep. Its offerings include an oral appliance with a customizable liner for optimal fit and sensor-enabled monitoring and management tools for clinicians and patients.
ROVENSO
Non Equity Assistance in 2018
ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.
Bloom Biorenewables
Non Equity Assistance in 2018
Bloom Biorenewables Ltd is a Swiss company established in 2019, specializing in the development of innovative technologies that convert wood and agricultural waste into renewable materials as substitutes for petroleum-based products. The company focuses on producing bio-based materials for various sectors, including fragrances, plastics, and textiles, thereby offering sustainable alternatives to fossil fuels. By introducing a novel approach to the production of biorenewable products and fuels, Bloom Biorenewables aims to make a significant impact in promoting the use of sustainable resources and addressing climate change challenges.
ALAnostics
Non Equity Assistance in 2018
ALAnostics is a specialty biopharmaceutical company that originated as a spin-off from the University of Geneva. It focuses on developing innovative tumor painting technology aimed at enhancing the surgical treatment of breast cancer. The company’s proprietary approach utilizes nanomedicines to create a fluorescent dye that targets early-stage tumors, facilitating real-time identification and removal during surgery. This technology, based on 5-ALA prodrugs, supports fluorescence-guided surgical procedures and incorporates light-activated antimicrobials, ultimately improving surgical outcomes and increasing the likelihood of saving patients' lives by ensuring complete tumor removal.
Aspivix
Non Equity Assistance in 2018
Aspivix develops innovative medical devices aimed at enhancing safety and comfort in gynecological procedures. Its flagship product, CAREVIX, employs suction technology to gently stabilize the cervix during procedures, reducing pain and minimizing risks such as bleeding and infections.
Nagi Bioscience
Non Equity Assistance in 2018
Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.
Kejako
Non Equity Assistance in 2018
Founded in 2015, Kejako is a Swiss medical device company specializing in ophthalmic surgery. It develops non-invasive solutions to address presbyopia, a gradual loss of visual accommodation, using advanced numerical simulations for personalized treatment.
Rapid Graft
Non Equity Assistance in 2018
Rapid Graft, established in 2018 and based in Zurich, Switzerland, specializes in developing innovative medical devices for precise skin graft harvesting. Their flagship product is a novel dermatome designed to efficiently obtain small split-skin grafts, aiming to enhance chronic wound treatment and facilitate future tissue engineering needs. The company's device enables surgeons to perform skin grafting procedures more effectively, minimizing the risk of infection, scarring, and requiring fewer specialized interventions or operating room resources.
Parquery
Non Equity Assistance in 2018
Founded in 2014, Parquery develops a web application that provides real-time on-street parking availability data using computer vision and machine learning. It offers smart routing options to users and enables parking managers to monitor usage patterns.
ChemAlive develops an online computational chemistry platform that automates calculations of molecular properties and synthetic reactions. Its cloud-based service enables users in academia, pharmaceuticals, and chemical industries to obtain accurate analytics without needing extensive computing infrastructure or software expertise.
GuestLee Property Management
Grant in 2017
GuestLee is a Swiss Property Management company.
In a exponentially growing market GuestLee positioning settled naturally by trust & recommendation to high-end property owners. 90% of their customers are seniors that worked hard to build real estate assets. With today’s versatile economical environment, living on savings or limited pension allowances, it is quite difficult to sustain life standards as well as to pay property maintenance fees. GuestLee is a decentralized business model using latest technologies to help seniors to generate revenue
Founded in 2017, Nanogence specializes in developing novel material solutions for the construction sector. It focuses on creating synthetic, tailor-made materials that enhance performance and reduce carbon emissions in applications such as construction, pharmaceuticals, and mobility.
Skypull develops airborne wind energy systems using autonomous drones that fly at higher altitudes, capturing strong winds and transmitting power via tether to ground-based generators. Founded in 2013, Skypull aims to provide clean, affordable energy while minimizing environmental impact.
Alogo Analysis
Grant in 2017
Founded in Switzerland in 2016, Alogo Analysis specializes in developing analytics tools for the equine industry. Its flagship product, Move, quantifies horse performance and monitors health evolution, providing data-driven insights to enhance training and prevent injuries.
Precision Vine
Grant in 2017
Precision Vine SARL is a company specializing in aerial decision support tailored for the wine industry, established in 2016 and based in Yverdon-les-Bains, Switzerland. The company collaborates with vineyard growers and winemakers to collect and analyze remote sensing data, which is then integrated into customized management plans. Precision Vine offers high-resolution hyper and multispectral aerial imaging along with vineyard-specific data services. These services help clients address various aspects of vineyard management, including heterogeneity, vine balance, irrigation systems, harvest planning, disease mapping, and nutritional needs. With a vast network of drone operators, Precision Vine currently provides its services across several countries, including the United States, France, Italy, Spain, Argentina, and Australia, all aimed at enhancing wine quality and operational efficiency.
BAABUK is a Swiss company founded in 2013 by a dynamic couple, Galina and Dan.
Their story began when Galina's parents gave Dan a pair of traditional Russian "Valenkis". In the past, these Russian felted boots were essential to fight the Siberian cold. So after trying them out in the snow, Galina and Dan had an idea! Why not preserve the "Valenki" ancestral know-how and create a revised pair of 100% wool shoes?
That's when the first BAABUK pair of shoes was born, and they didn't stop there...
Lymphatica Medtech
Grant in 2017
Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.
Social Fabric
Grant in 2017
Social Fabric is a sustainable textile center committed to promoting the use of textiles and clothing that minimize ecological and social footprints. The company operates a community-based association that emphasizes the integration of refugees in Switzerland and sustainability in textile production. Through its atelier, Social Fabric aims to provide customers with meaningful and customized garments that reflect principles of a circular economy, innovative technology, and ethical labor practices. By combining decentralised manufacturing with a focus on sustainability, Social Fabric enables individuals to access high-quality, sustainable textile products tailored to their needs.
RiskTalk develops an enterprise software tool that enables employees to raise concerns about issues affecting core values and day-to-day priorities. The platform supports bottom-up, blame-free reporting of risks, captures, flags, and logs issues, assigns them to responsible colleagues, provides feedback, and tracks actions in real time to help management turn discussions into actionable outcomes. Founded in 2016 and based in Lausanne, Switzerland, with an additional office in Kent, United Kingdom.
LEDsafari is a Lausanne, Switzerland based company founded in 2014 that provides hands-on training programs to enable individuals to design and build solar LED lamps, and operates an educational platform with ready-to-use content and learning tools. The company targets sustainability education in schools, universities, NGOs, businesses, and other institutions, and markets a solar kit that has sold around 15,000 units in 15 countries through its online platform. It plans to expand with augmented reality and mobile technologies to enrich the learning experience, aiming to empower the next generation to tackle climate change by delivering practical knowledge in solar technology and sustainable design.
GliaPharm is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders by targeting glial cells to support brain metabolism. It has developed the GliaX platform to identify drugs that modulate glial activity and energy metabolism. The platform combines high-throughput screening using enzymatic and primary-cell assays with metabolic characterization of compounds in vitro in primary brain cell cultures and in vivo in rodent brains. Research includes various rodent models of brain aging, Alzheimer's disease, and ALS, with selective contract research organizations handling parts of the drug-development process. Founded in 2016 and based in Geneva, GliaPharm pursues glia-mediated neuroprotection and maintenance of cognitive function.
TWIICE is a Swiss company based in Lausanne, founded in 2015, that specializes in the development and manufacture of lower limb exoskeletons. These innovative devices are designed specifically to assist paraplegic individuals in standing and walking again, catering to various morphologies and medical conditions. The exoskeletons feature electric motors that enable movement in the hip and knee joints, providing users with the ability to regain the sensations and benefits associated with standing and walking. TWIICE aims to enhance the independence of individuals with mobility challenges, allowing them to participate more fully in daily activities and improve their overall quality of life.
Imverse is a Swiss-based 3D graphics software company established in 2017. Headquartered in Plan-les-Ouates, Geneva, the company specializes in deploying volumetric technology for Location Based Entertainment (LBE). Imverse offers real-time simulation and modeling tools that transform 2D images into immersive, 3D virtual environments suitable for live streaming, gaming, and remote work applications. The company's core product is a live volumetric video platform designed for enterprise use, enabling organizations to stream real-time three-dimensional holograms using depth cameras and reality capture software.
Sleepiz
Non Equity Assistance in 2017
Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.
TieTalent
Non Equity Assistance in 2017
TieTalent is a Swiss tech-focused recruitment platform that connects IT and digital marketing professionals with companies. The platform combines artificial intelligence with human expertise and psychometric data analysis to match vetted technology talent efficiently. It aims to improve the quality of hires while reducing time and cost, and centers on a candidate-focused approach that eliminates motivation letters, traditional applications, and spam calls to simplify the recruitment process.
Securaxis
Non Equity Assistance in 2017
Securaxis develops, installs, and operates innovative safety and security solutions, focusing on real-time geolocalized security information. Founded in 2018 as part of the BIC of CERN Technologies in Switzerland, the company is recognized for its achievements, including participation in various startup programs and awards. Securaxis utilizes a smart acoustic sensor connected to a wireless network to analyze and classify sounds in urban environments, allowing for accurate reporting of potential security threats. This technology enables organizations to enhance safety measures by making informed decisions based on real-time data. The team consists of eight experts in machine learning, acoustics, data management, and entrepreneurship, who have successfully developed and commercialized a mobile security application for notable clients, including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations.
Versantis
Series A in 2017
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.
AirDAO
Non Equity Assistance in 2017
AirDAO is a Swiss-based startup focused on revolutionizing global supply chains via blockchain technology. It operates Ambrosus, an open-source platform designed for decentralized finance (DeFi). AirDAO enables secure, autonomous supply chain management through reliable product history recording and transparent commercial transactions. The platform aims to enhance distribution processes and empower consumers with product origin and composition information. Users can earn token rewards by operating Ambrosus Network validator nodes and accessing innovative dApps via a unified dashboard.
Artmyn SA is a Swiss company specializing in the digitization of visual artworks, providing a comprehensive platform that allows users to interact with high-quality digital replicas of art. Founded in 2015 and based in Belmont-sur-Lausanne, Artmyn offers a range of services including digital guided tours, online galleries, conservation monitoring tools, and interactive e-catalogs. Its unique portable scanner captures extensive data about artworks, enabling true-to-life visualizations accessible via web browsers on various devices. This technology enhances the experience for museums, galleries, auction houses, and both private and institutional collectors, facilitating more transparent transactions in the art market. Artmyn aims to transform the way art is experienced and appreciated through innovative digital solutions.
Versantis
Non Equity Assistance in 2016
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.
Fastree3D
Non Equity Assistance in 2016
Fastree3D is a fabless semiconductor company founded in September 2013 as a spin-off from EPFL Lausanne, Switzerland. It specializes in the development of three-dimensional imaging sensors that enable real-time recognition and distance measurement of fast-moving objects, facilitating driving assistance and autonomous navigation. The company employs advanced complementary metal-oxide-semiconductor (CMOS) fabrication processes to create precision sensors suitable for both consumer electronics and industrial applications. Fastree3D's technology allows clients to design vehicles and machines capable of continuously monitoring their surroundings, significantly enhancing their ability to detect and locate fast-moving objects in three dimensions. Additionally, Fastree3D B.V., a subsidiary of the company, collaborates with TU-Delft in the Netherlands to further advance its research initiatives.
Carbon Delta
Grant in 2016
Carbon Delta AG is a specialized firm focused on assessing the impact of climate change on publicly traded companies. Operating as a subsidiary of MSCI Barra (Suisse) Sàrl since 2019, Carbon Delta has developed an evaluation system that identifies and analyzes the climate change resilience of these companies. The firm's model calculates the climate change value at risk for thousands of organizations, helping investors understand how climate risk may affect company valuations. By exposing climate risks in the financial markets, Carbon Delta enables companies to safeguard assets, enhance performance, and achieve sustainability objectives.
SUN bioscience
Grant in 2016
SUN bioscience SA is a bioengineering company based in Epalinges, Switzerland, founded in 2016. It specializes in developing drug culture platforms for personalized medicines using patient-specific organoids. The company's proprietary high-throughput 3D microwell platform enables the creation of self-organizing 3D miniature tissues with organ-mimicking functions from stem cells. These organoids serve as powerful human in vitro models for assessing pharmaceutical efficacy and toxicity early in drug development, addressing current limitations in scalability and automation of organoid culture. SUN bioscience's technology aims to advance drug discovery by providing insights into drug performance outside of animal or human testing.
SimplicityBio
Grant in 2016
SimplicityBio SA is a biotechnology company based in Monthey, Switzerland, founded in 2013 by Matthew Hall, Pedro Faustino, and Miguel Barreto. The company specializes in developing an artificial intelligence-based platform designed to analyze biological, clinical, and digital data streams, facilitating the extraction of knowledge and insights that expedite the development of biomarker signatures throughout various stages, from target identification to pre-clinical and clinical phases. Its services encompass biomarker discovery and ranking, signature creation, and the enhancement of existing signatures, catering to the molecular diagnostic market. In addition to its analytical capabilities, SimplicityBio also focuses on developing scientific innovations, intellectual property, and white paper technologies for its clients. As of March 2019, SimplicityBio operates as a subsidiary of Precision for Medicine, Inc.
Gait Up SA is a Swiss company based in Lausanne, founded in 2013 as a spin-off from the University Hospital of Lausanne and the Swiss Institute of Technology. Specializing in motion analytics, Gait Up manufactures wearables used in smartwatches and other hardware to provide objective evaluations of health and performance. With over 15 years of scientific expertise in movement analysis, the company develops innovative products that leverage wearable sensor technology. Gait Up has established a strong presence in the market, serving over 50 customers across academia, clinics, and various industries in Europe, Canada, the United States, and Asia. Since June 2017, Gait Up has operated as a subsidiary of MindMaze SA.
SwissDeCode is a Swiss company based in Renens that specializes in food safety and compliance services for food manufacturers. Founded in 2016, it offers rapid onsite DNA testing solutions that allow production facilities to confirm food authenticity, safety, and origin. By providing plug-and-play systems, SwissDeCode enables factories to obtain food safety and quality certifications within the same work shift, facilitating immediate decision-making for inspectors. This approach not only addresses contamination threats but also transforms them into sustainable opportunities for food producers.
Planet Hort - learning sustainability in a playful way“ is the first organization in Switzerland that aims to integrate Education for Sustainable Development into after-school care. Their activities and courses deal with the five main sustainability topics biodiversity, cultural plurality, consumption, energy and waste. With their program they want to encourage children at an early stage to engage in a sustainable interaction with the environment. And empower day-care personal to adopt their approach.
Planet Hort - learning sustainability in a playful way“ wants to integrate Education for Sustainable Development into after-school care.
TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements aimed at enhancing sustainable animal farming practices. Founded in 2015 and based in Root, Switzerland, the company has developed a unique triple active probiotic product that addresses challenges faced in intensive animal farming, such as improving digestion, enhancing feed conversion ratios, and reducing disease and pollution. The probiotic supplement is grounded in research from the École Polytechnique Fédérale de Lausanne, focusing on the enhancement of gut microbiota, which is crucial for food metabolism and immune defense. Targeting animal farmers, feed suppliers, and large retailers, TwentyGreen aims to capture a 10% share of the rapidly growing global animal feed probiotic market, which exceeds $4 billion annually. The commercialization of their product involves rigorous research and development in collaboration with esteemed academic partners to meet regulatory standards for animal feed.
Eyeware
Non Equity Assistance in 2016
Founded in 2016, Eyeware develops software-only head and eye tracking solutions for webcams and 3D cameras. Its patent-pending computer vision algorithms enable accurate, real-time gaze tracking without specialized hardware, benefiting applications such as gaming, research, accessibility, automotive, and healthcare.
CyanoGuard AG is a Swiss chemical technology company founded in 2016, specializing in innovative solutions for the monitoring and detection of cyanide across various sectors, including mining, food safety, wastewater, and healthcare. The company offers a range of products, including the CyanoKit, a semi-quantitative cyanide test, the CyanoGuard mobile quantitative monitoring test, and the Cyano.iO online monitoring and optimization solution. CyanoGuard's technology enables rapid and accurate cyanide detection without the need for specialized training or equipment, making it suitable for use in remote locations. The company's methods are designed to selectively detect cyanide in liquid samples while resisting interference from common substances, thereby providing clients with efficient tools for tracking and managing cyanide levels in diverse applications.
Smart Home Technology
Grant in 2016
Smart Home Technology GmbH, founded in 2014 and based in Zurich, Switzerland, specializes in the development of smart devices and home automation products. The company is dedicated to enhancing existing systems by providing ultra-low power, reliable, and cost-effective solutions derived from scientific research and advanced technological expertise. Smart Home Technology employs zero-standby power technology, enabling the operation of electrical devices and household appliances with no standby energy losses. By focusing on security and communication concepts, the company offers highly efficient systems integrated with smart software, catering primarily to business customers in the cleantech and smart home sectors.
Fastree3D
Angel Round in 2016
Fastree3D is a fabless semiconductor company founded in September 2013 as a spin-off from EPFL Lausanne, Switzerland. It specializes in the development of three-dimensional imaging sensors that enable real-time recognition and distance measurement of fast-moving objects, facilitating driving assistance and autonomous navigation. The company employs advanced complementary metal-oxide-semiconductor (CMOS) fabrication processes to create precision sensors suitable for both consumer electronics and industrial applications. Fastree3D's technology allows clients to design vehicles and machines capable of continuously monitoring their surroundings, significantly enhancing their ability to detect and locate fast-moving objects in three dimensions. Additionally, Fastree3D B.V., a subsidiary of the company, collaborates with TU-Delft in the Netherlands to further advance its research initiatives.
Artmyn
Non Equity Assistance in 2016
Artmyn SA is a Swiss company specializing in the digitization of visual artworks, providing a comprehensive platform that allows users to interact with high-quality digital replicas of art. Founded in 2015 and based in Belmont-sur-Lausanne, Artmyn offers a range of services including digital guided tours, online galleries, conservation monitoring tools, and interactive e-catalogs. Its unique portable scanner captures extensive data about artworks, enabling true-to-life visualizations accessible via web browsers on various devices. This technology enhances the experience for museums, galleries, auction houses, and both private and institutional collectors, facilitating more transparent transactions in the art market. Artmyn aims to transform the way art is experienced and appreciated through innovative digital solutions.
Biowatch SA, founded in 2015 and headquartered in Martigny, Switzerland, has developed a biometric identification system that integrates into the buckle of a watchband, allowing for secure authentication through the unique patterns of veins on a user's wrist. The Biowatch functions as a user-friendly biometric reader, providing a security solution for mobile payments and smart device interactions. Users can enroll their vein patterns via an application, which enables them to connect their Biowatch to various devices and applications. Once enrolled, users can authenticate themselves by matching their vein patterns, allowing them to access services and premises without the need for traditional keys, passwords, or PIN codes. The technology aims to simplify and enhance security measures in everyday transactions and interactions.
Rayform
Non Equity Assistance in 2016
Rayform SA is a Swiss company specializing in innovative light redirection technology that enables unique design possibilities for luxury products and packaging. Founded in 2016 and based in Ecublens, the company employs a proprietary computer algorithm to calculate the three-dimensional surfaces necessary for creating target images from light. By modifying the shape of transparent or reflective surfaces according to the algorithm's specifications, Rayform's technology redirects incoming light to produce clear and detailed images on adjacent surfaces. This capability not only enhances the visual appeal of consumer products but also aids artists, designers, and brands in crafting memorable experiences while providing a means to combat counterfeiting.
Rqmicro
Non Equity Assistance in 2016
Rqmicro is a Swiss company based in Zurich, founded in 2013, that specializes in pathogen separation and detection technology. The company has developed proprietary reagents and instruments for rapid microbiological testing, which provide accurate results in under one hour. Rqmicro's technology is utilized for the rapid assessment of water and food safety, enabling clients to detect dangerous pathogens effectively. By delivering quantitative data on contamination, Rqmicro's solutions enhance the overall safety of water and food products, addressing critical public health concerns.
Pingen is an online solution to send documents by letter post for private, business, and software integration. Users can either upload PDFs from their desktops or fetch files online from their Dropbox, Google Drive, and Microsoft Skydrive accounts.
Pingen was launched in 2010 and is operated from Zürich, Switzerland.
incredX AG is a Swiss-based healthcare company founded in 2011 by a small team of former executives and surgeons from the AO Foundation. The company focuses on leveraging modern technologies to create a universal platform for recording, tracking, and sharing Patient Outcome Measures across global healthcare systems. incredX develops a cloud-based healthcare system that facilitates collaboration among medical professionals and patients, allowing them to exchange treatment and outcome data effectively. This innovative approach enables healthcare providers to quickly identify and adopt proven best practices, ultimately aiming to improve patient care and outcomes.
MagnebotiX, founded in 2014 and based in Zurich, specializes in the development and production of advanced magnetic manipulation systems. The company focuses on creating magnetic field generators and micromagnetic agents, utilizing their extensive expertise in the field. Their innovative products are designed to facilitate both fundamental and applied scientific research, enabling users to perform complex micromanipulation tasks wirelessly. MagnebotiX’s systems are particularly valuable as untethered mechanical probes, allowing access to otherwise unreachable areas and enabling targeted cargo delivery for minimally invasive biological studies. By leveraging the transmission of power and guidance through applied magnetic fields, MagnebotiX supports a wide range of research applications in the field of magnetic phenomena and magnetic microrobots.
Biowatch
Non Equity Assistance in 2015
Biowatch SA, founded in 2015 and headquartered in Martigny, Switzerland, has developed a biometric identification system that integrates into the buckle of a watchband, allowing for secure authentication through the unique patterns of veins on a user's wrist. The Biowatch functions as a user-friendly biometric reader, providing a security solution for mobile payments and smart device interactions. Users can enroll their vein patterns via an application, which enables them to connect their Biowatch to various devices and applications. Once enrolled, users can authenticate themselves by matching their vein patterns, allowing them to access services and premises without the need for traditional keys, passwords, or PIN codes. The technology aims to simplify and enhance security measures in everyday transactions and interactions.
Akselos is a technology company that develops Integra, a cloud-based engineering simulation platform and digital twin for asset-centric industries. The platform enables engineers to build high-resolution, component-based models of large systems and run parameterized simulations that cover geometric and physical properties, loads, and boundary conditions. It supports hydrodynamic analysis of floating assets and structural assessment of fixed offshore installations, as well as analysis of composites used in wind blades, pressure vessels, pipelines, and rotating machines. Designed for design, virtual prototyping, and real-time monitoring, Integra leverages fast, patented algorithms that can model large-scale assets on portable hardware. The company's vision emphasizes preventative maintenance and reduced unplanned downtime through real-time asset condition and future-state insights, often described as a digital twin with sensors and big data analytics. Akselos was founded in 2011 in Lausanne, with a Cambridge, Massachusetts office and operations in Europe, the USA, and Southeast Asia.